How do I calculate the total daily insulin dose when switching from Humalog (insulin lispro) to a 70/30 insulin mixture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Total Daily Insulin Dose When Switching from Humalog to 70/30 Insulin

When switching from Humalog (rapid-acting insulin lispro) to a 70/30 premixed insulin, start with the same total daily insulin dose divided into two equal injections given before breakfast and dinner, administered 30 minutes before meals. 1

Initial Dose Calculation

  • Calculate your current total daily dose (TDD) of Humalog by adding all rapid-acting insulin doses given throughout the day 2
  • Use this same TDD for the 70/30 insulin, splitting it equally: give 50% before breakfast and 50% before dinner 1, 3
  • For example, if you're taking 40 units total of Humalog daily, start with 20 units of 70/30 before breakfast and 20 units before dinner 1

Important Dosing Adjustments

If you are currently taking more than 0.6 units/kg/day of insulin at home, reduce the total daily dose by 20% when switching to prevent hypoglycemia. 2 This is particularly important because:

  • Premixed 70/30 insulin carries a 4-6 times higher risk of hypoglycemia compared to other insulin regimens 3
  • The fixed ratio of 70/30 (70% intermediate-acting, 30% rapid-acting) provides both basal and prandial coverage simultaneously, which can lead to insulin stacking if dosed too aggressively 1

Titration Strategy After Initiation

  • Adjust doses every 2 weeks based on fasting blood glucose, targeting 90-150 mg/dL 1
  • If ≥50% of fasting values exceed goal: increase dose by 2 units 1
  • If >2 fasting values per week are <80 mg/dL: decrease dose by 2 units 1

Critical Safety Warnings

Premixed 70/30 insulin has been associated with unacceptably high rates of hypoglycemia in hospital settings and is not recommended for inpatient use. 2 In outpatient settings:

  • Patients must eat similar amounts of carbohydrates at consistent meal times to match the fixed insulin doses 3
  • Carry quick-acting carbohydrates at all times due to elevated hypoglycemia risk 3
  • Use lower starting doses (closer to 0.1 units/kg/day) for patients at high risk: age >65 years, renal failure, or poor oral intake 1

When This Switch May Not Be Appropriate

Do not use 70/30 insulin in patients with unpredictable eating patterns or those requiring flexible dosing, as the fixed 70:30 ratio limits adjustment of basal versus prandial components separately. 1 Consider maintaining a basal-bolus regimen (separate basal and rapid-acting insulins) instead for these patients. 2, 3

Common Pitfall to Avoid

Do not continue escalating 70/30 doses indefinitely if A1C remains above target. 1 When basal insulin exceeds 0.5 units/kg/day, consider adding a GLP-1 receptor agonist or converting to a basal-bolus regimen rather than continuing to increase premixed insulin, as this increases hypoglycemia risk without proportional glycemic benefit. 1

References

Guideline

Insulin Dosing Guidelines for Novolin 70/30

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Therapy with Novolog Mix 70/30

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.